Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation
This is exactly why the retatrutide dosage chart escalates gradually, giving your GI system time to adapt to each new level of GLP-1 stimulation
The Double Mechanism of Risk Increased Ketogenesis from Lower Insulin When insulin levels drop: Fat breakdown increases Free fatty acids are converted to ketones in the liver Blood ketone levels rise Even if glucose levels are normal or mildly elevated, ketone accumulation can lead to metabolic acidosis
Lavender Sky Health is not subscription-based for compounded GLP-1s